Tate & Lyle PLC Board Changes

| Filed in:

Dr Gerry Murphy is appointed as a non-executive director and Chairman-designate of the Company.

Board Changes

 

Tate & Lyle PLC (the “Company”) announces the appointment of Dr Gerry Murphy as a non-executive director and Chairman-designate of the Company.  He will join the Board on 1 January 2017 and will succeed Sir Peter Gershon as Chairman of the Company on 1 April 2017 following Sir Peter’s retirement as a Director on 31 March 2017.

Dr Murphy is Chairman of The Blackstone Group’s principal European entity. His early career was in the food and drinks sector, primarily with Grand Metropolitan plc (now Diageo plc) and Greencore Group plc, where he was CEO, before becoming CEO of Exel plc, Carlton Communications plc and most recently Kingfisher plc (2003 to 2008). He is a non-executive Director of British American Tobacco plc and Intertrust NV and has held non-executive directorships in a number of London-listed companies including Merlin Entertainments plc from 2013 to 2015. Further biographical details are attached.

Sir Peter Gershon said “I am delighted to welcome Gerry to the Board of Tate & Lyle and very much look forward to working closely with him during the first quarter of calendar 2017 as we transition the Chairmanship. Gerry’s extensive experience in the food industry and as chief executive, investor and independent director in leading international companies equips him well to guide Tate & Lyle in the years ahead.”

Gerry Murphy said “I am honoured to succeed Sir Peter as Chairman of Tate & Lyle and I am very excited about working with Javed Ahmed, the Board and the leadership team to help deliver the Company’s growth agenda. Having started my career in the food industry, joining Tate & Lyle feels like coming home.”

Upon Dr Murphy’s appointment as a non-executive director, he will join the Corporate Responsibility and Nominations Committees and will assume chairmanship of the Nominations Committee with effect from 1 April 2017.

It is further announced that, having led the Chairman succession process, Liz Airey has informed the Board that she intends to step down as Senior Independent Director on 31 December 2016 and will retire from the Board at the Annual General Meeting in July 2017. Douglas Hurt will assume the role of Senior Independent Director, in addition to his role as Chairman of the Audit Committee, with effect from 1 January 2017.

Sir Peter Gershon, said “I would like to thank Liz for her ten years of outstanding service and significant contribution to the Board and, in particular, for her time served as Chairman of the Audit Committee and as Senior Independent Director.”

There are no further disclosures to be made in connection with Dr Murphy’s appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority’s Listing Rules. Biographical details for Dr Murphy are attached.
 

About Dr Gerry Murphy

Gerry Murphy, aged 61, has been a Senior Managing Director in Blackstone’s Private Equity group and Chairman of its principal European entity since 2008. He is also Chairman of Invest Europe, the Brussels-based industry association representing Europe’s private equity, venture capital and infrastructure firms and their investors.

Before joining Blackstone in 2008, Gerry Murphy was CEO of Kingfisher plc (2003 to 2008) and previously CEO of Carlton Communications plc (2000 to 2003), Exel plc (1995 to 2000) and Greencore plc (1991 to 1995).

Earlier in his career, he held senior operating and corporate positions with Grand Metropolitan plc (now Diageo plc) in Ireland, the UK and the USA.

He is a non-executive director of British American Tobacco plc and Intertrust NV and has previously served on the boards of Merlin Entertainments plc, Reckitt Benckiser plc, Abbey National plc and Novar plc.  

Dr. Murphy was educated in Ireland and received his PhD in food technology from University College Cork and MBS in marketing from University College Dublin.

About Tate & Lyle: 
Tate & Lyle PLC is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fibre fortification, our Food & Beverage Solutions business develops solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings. Our Primary Products business produces nutritive sweeteners, industrial starches used in paper and packaging, acidulants and products used for animal nutrition.

We have around 4,200 employees working in more than 60 locations across 30 countries. Tate & Lyle’s purpose is Improving Lives for Generations and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on TwitterLinkedin or Facebook.

Contact the press team

Contact a member of our press office if you’re a member of the media looking for company information or if you have a specific enquiry

On
Off-white